Pitavastatin Calcium
Brand name: Livalo
Rank #288 of 500 drugs by total cost
$40.8M
Total Cost
69,636
Total Claims
$40.8M
Total Cost
3,199
Prescribers
$587
Cost per Claim
3,677
Beneficiaries
128,513
30-Day Fills
$13K
Avg Cost/Provider
22
Avg Claims/Provider
About Pitavastatin Calcium
Pitavastatin Calcium (sold as Livalo) was prescribed 69,636 times by 3,199 Medicare Part D providers in 2023, costing the program $40.8M. At $587 per claim, this is a high-cost medication.
Related Drugs by Cost
| # | Drug | Total Cost | Claims |
|---|---|---|---|
| 285 | Travoprost (Travoprost) | $41.5M | 178,599 |
| 286 | Alendronate Sodium (Alendronate Sodium) | $41.4M | 3,414,824 |
| 287 | Daptomycin (Daptomycin) | $41.2M | 41,245 |
| 288 | Pitavastatin Calcium (Livalo) | $40.8M | 69,636 |
| 289 | Bromfenac Sodium (Prolensa) | $40.8M | 121,284 |
| 290 | Suvorexant (Belsomra) | $40.7M | 87,327 |
| 291 | Atogepant (Qulipta) | $40.7M | 32,955 |
Data from CMS Medicare Part D Prescriber-Drug Public Use File, 2023. Methodology